Abstract: The syringe comprises a body containing the liquid and having fitted thereto an endpiece for fastening a needle carrier. The safety device comprises a protective sheath and a syringe support that is received inside the sheath. The sheath and the support are axially movable relative to each other between two positions, namely an uncovered position of the needle, and a retracted position of said needle. The support includes anti-rotation means for constraining it in rotation about its axis and comprising at least one pawl urged resiliently into a position in which the pawl is designed to co-operate with complementary anti-rotation means of the fastener endpiece. The sheath and the support include complementary anti-rotation means for constraining them in rotation relative to each other about their axes and activated at least when the sheath and the support are in their uncovered position of the needle.
Abstract: A drug delivery device is configured to receive a cartridge containing a drug. The drug delivery device comprises a content display for displaying information related to one of the cartridge and the drug contained in the cartridge. The content display is configured to selectively display at least two different pieces of information and is configured to be adjusted mechanically to display one of the pieces of information. Furthermore, a set of the drug delivery device and a plurality of mountable elements is provided, wherein the mountable elements differ in their shapes and wherein the displayed piece of information is specific for the shape of the mountable element.
Abstract: A filtered needle for use in administering a liquid payload, including a needle and connector portion and a filtering needle cap. The filtering needle cap including a distal open end in fluid communication via an internal channel with a proximal open end of the filtering needle cap. The filtering needle cap proximal end sized to receive the distal end of the hub within the proximal end of the filtering needle cap to reversibly engage the hub when needle distal end is inserted into the internal channel. The filtering needle cap including a filter element and a seal to seal around an outside diameter of the hollow needle so that liquid payload is drawn into the lumen in the hollow needle as liquid payload is filtered and drawn into the fluid fitting. The filtering needle cap is designed to limit a dead volume of liquid payload drawn into the filtering needle cap but not entering into the distal end of the hollow needle.
Type:
Grant
Filed:
November 16, 2015
Date of Patent:
June 6, 2017
Assignee:
CARRTECH LLC
Inventors:
Sue E. Carr, Jessie Delgado, Edward Browka, Charles E. McCall, Jr., David L. Foshee
Abstract: A device for treating living cells by plasmaporation contains, in addition to devices for generating plasma and generating a field, devices for mixing and transporting active substances, predominantly in the form of nano and microparticles, for affecting the metabolism of the cells.
Type:
Grant
Filed:
August 8, 2010
Date of Patent:
May 30, 2017
Assignee:
LEIBNIZ-INSTITUT FUER PLASMAFORSCHUN UND TECHNOLOGIE E.V
Inventors:
Klaus-Dieter Weltmann, Thomas Von Woedtke, Olaf Lademann
Abstract: A resettable dose setting mechanism for a drug delivery device comprising a driver for driving a spindle of the drug delivery device is provided. Said driver comprises a first component and a second component rotationally coupled to said first component. During resetting of said drug delivery device, said first component is rotationally decoupled from said second component.
Abstract: A syringe or carpule includes a cylinder that surrounds a cavity and comprises an end that has an access to the cavity, membrane seals the access and has a puncture area that can be punctured by a needle. A two-part cap has a predetermined breaking line and spans the membrane. A cover device covers the puncture area of the membrane in a sterile manner and comprises a sealing area spanning the puncture area. The sealing area covers the puncture area in a sterile manner regardless of axial forces to be applied in the area of the predetermined breaking line.
Abstract: Methods and systems for providing modular components in an integrated infusion device and analyte monitoring system where the components are independently replaceable are provided.
Abstract: A method for coaxially connecting a first plastic tube (10, 110) to a second plastic tube (20, 120), said plastic tubes (10, 20) in particular being provided as part of a medical catheter (102), the two plastic tubes (10, 20) being connected by way of a tubular connecting piece (50), characterized in that the first plastic tube (10) and/or the second plastic tube (20) are integrally molded from the outside onto the tubular connecting piece (50) using a forming process such that an adhesive and/or positive connection is produced.
Abstract: A needle assembly for an injection pen (22) has a sleeve (21) supporting internally a double-ended needle having an injection end and a non-injection end (25). The end of the sleeve surrounding the non-injection end (25) of the needle is divided into deformable segments (28) and is internally threaded for interengagement with a threaded boss (23) of the injection pen (22). A collar (29) is mounted on the sleeve (21) for sliding movement between a first position where the collar (29) overlies the segmented end and maintains interengagement of the threads at that end with those of the injection pen boss (23) and a second position where the segments may expand radially to come free of the injection pen boss (23). The needle may be mounted on a carrier (68) slidable with respect to the sleeve (21), the carrier (68) being coupled to the sleeve (21) for movement thereby.
Abstract: A safety shield for use with a hypodermic syringe device is disclosed. The safety shield is moveable relative to the syringe barrel between retracted position and a needle containing position. In the retracted position, the syringe device may be used to inject the needle into the patient. After the medication has been injected or as the needle is withdrawn from the patient, in its operative mode the shield automatically extends from its retracted position to a needle containing position to shield the point of the needle to prevent accidental sticks and without further input from the operator to render the syringe unusable after a single injection.
Abstract: This Invention relates to a method for achieving Focused Resonance Nanopermeabilization (FORN), which can be utilized in a novel anticancer therapy, and other selective permeabilization therapy and a machine to carryout the said method, where the transient permeabilization of cells by Focused Resonance pulses induces a significant increase of anti-tumor drug concentration in tumor or other interested cells. This invention can be successfully applied to the treatment of tumors in humans and Animals by using antimitotic drugs, chemotherapy. The invention is also useful in transpermeabilization of drug molecules for non cancer applications like vaccine and delivery of genetic materials for therapeutic purposes. Focused Resonance Nanopermeabilization (FORN), would enable a practical solution to a whole body application in its natural environment, without implanting electrodes or external probes, FORN is completely non-invasive. This invention also relates to an apparatus for carrying out the above method.
Abstract: A treatment device includes: a balloon; a biologically active agent part applied on an outer surface of the balloon; a protective sleeve encircling the balloon and being displaceable proximally; and an interposed member having a self-expanding function arranged between the balloon and the protective sleeve. When the protective sleeve is moved proximally in order for the balloon to be exposed to the inside of a blood vessel, the presence of the interposed member prevents the biologically active agent part from being scraped and peeled off by the inner surface of the protective sleeve.
Abstract: A driver for driving a spindle of a drug delivery device is provided. Said driver comprises a first component and a second component rotationally coupled to said first component. During resetting of said drug delivery device, said first component is rotationally decoupled from said second component.
Abstract: An auto-injector for administering a dose of a liquid medicament (M) is presented comprising an elongate housing arranged to contain a syringe with a hollow needle and a stopper for sealing the syringe and displacing the medicament (M), the housing having a distal end (D) and a proximal end (P) with an orifice intended to be applied against an injection site, wherein the syringe is slidably arranged with respect to the housing. The auto-injector contains a spring means capable of, upon activation, pushing the needle from a covered position inside the housing into an advanced position through the orifice and past the proximal end (P), operating the syringe to supply the dose of medicament (M), and retracting the syringe with the needle into the covered position after delivering the medicament (M). There is also an activating means arranged to lock the spring means in a pressurized state prior to manual operation.
Type:
Grant
Filed:
August 8, 2013
Date of Patent:
March 14, 2017
Assignee:
Sanofi-Aventis Deutschland GMBH
Inventors:
Yannick Hourmand, Timothy Donald Barrow-Williams, Matthew Ekman
Abstract: A vascular access device having a fluid chamber in which UV-C radiation is emitted to irradiate pathogens contained in an infusate flowing though the fluid chamber.
Abstract: An apparatus for performing a vascular treatment. In some embodiments, the apparatus comprises a vascular therapy device comprising a vascular treatment device and a feeder. The vascular treatment device can connect to a wire configured for use in vascular treatment. The vascular treatment device can rotate the wire. The feeder can be configured for controller the longitudinal translation of the wire. The feeder and the vascular treatment device can be independently or combinedly controlled.
Abstract: The invention relates to a clutch mechanism for the transmission of a rotary movement from a gear arrangement comprising a first gear member and a second gear member. The first gear member is rotatable about a longitudinal axis but axially fixed wherein the first gear member, upon rotation, is arranged for translatively moving a second gear member which is prevented from rotating. The clutch mechanism comprises a circumferential shoulder arranged at the second gear member and at least one or a number of resilient clutch fingers with respective inclined inner surfaces arranged at the first gear member, the shoulder arranged for increasingly pressing against the inclined surfaces thereby flexing the clutch fingers outward when the shoulder reaches the clutch fingers in the course of its translation. The clutch mechanism further comprises tube arranged around the clutch fingers, the tube having a number of internal longitudinal splines for engaging the flexed-out clutch fingers.
Type:
Grant
Filed:
February 16, 2011
Date of Patent:
February 21, 2017
Assignee:
Sanofi-Aventis Deutschland GMBH
Inventors:
Matthew Ekman, Timothy Donald Barrow-Williams, Yannick Hourmand
Abstract: A dressing includes a transparent film layer having a top side, an opposite bottom side, and an insertion site viewing portion. The bottom side has an adhesive portion and an adhesive-free portion. The adhesive-free portion is disposed within the viewing portion. An antimicrobial member having a top side and an opposite bottom side is disposed in the viewing portion. A portion of the antimicrobial member is adhered to the film layer adhesive portion, and a portion of the antimicrobial member is disposed in the adhesive-free portion. The antimicrobial member includes an outer edge and an opening disposed within the outer edge. The opening is disposed in the adhesive-free portion. A catheter extending from an insertion site is receivable through the opening in the antimicrobial member. The antimicrobial member surrounds the insertion site when the dressing is applied to a patient.
Abstract: An implantable infusion device includes a voltage boost circuit configured to selectively generate an output voltage from a first voltage provided by a battery. The voltage boost circuit includes a signal generation circuit configured to generate control signals and a charge pump circuit configured to generate the output voltage in response to the control signals. In response to a request for a predetermined voltage, the signal generation circuit generates the control signals using a first profile for a first period of time, and generates the control signals using a second profile for a second period of time subsequent to the first period. The charge pump circuit increases the output voltage to (i) an intermediate voltage less than the predetermined voltage in response to the first profile of the control signals, and (ii) the predetermined voltage in response to the second profile of the control signals.
Type:
Grant
Filed:
April 27, 2012
Date of Patent:
January 31, 2017
Assignee:
Medtronic, Inc.
Inventors:
Charles Randall Rogers, Christopher Ambri
Abstract: The subject matter relates a catheter having a helical or spiral tip defining an aspiration port for removing obstructions from blood vessels.